InvestorsHub Logo
Followers 46
Posts 6311
Boards Moderated 0
Alias Born 06/17/2009

Re: abew4me post# 312843

Sunday, 06/06/2021 7:53:49 AM

Sunday, June 06, 2021 7:53:49 AM

Post# of 464615

If the announcement is made first thing in the morning, I expect it to be favorable for Biogen.



I thought there was going to be a hearing/presentation on Monday, not a decision necessarily.

One of my concerns about FDA's approval of adu* is that it becomes the SOC. Then, if blarcamesine receives approval in a year, will it be the new SOC or only a drug that is better? If the latter, then other drugs that are not a efficient as blarcamesine might be approved as being better than adu* though not Anavex's drug.

IMO, it would be much, much better for Anavex that blarcamesine be the first new SOC rather than a low bar set by adu* that other drugs can hop over though mot as efficient as blarcamsine.



ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News